Sign in

CIK 0001789972

  • Non-accelerated filer
  • Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813879991
Phone
+1 617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Planned sale Chief Scientific Officer sold 11,742 shares at an average $14.08 ($165,366)
  2. 4 Open-market sale Chief Legal Officer sold 3,742 shares at $13.62 ($50,966)
  3. 4 Open-market sale President and CEO sold 16,381 shares at $13.62 ($223,109)
  4. 4 Open-market sale Chief Financial Officer sold 4,398 shares at $13.62 ($59,901)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Chief Financial Officer acquired 68,750 shares (grant or award)
  10. 4 Grant or award Chief Scientific Officer acquired 57,500 shares (grant or award)
  11. 4 Open-market sale Chief Scientific Officer sold 416 shares at $12.03 ($5,004)
  12. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $12.30 ($49,200)
  13. 4 Grant or award Chief Financial Officer acquired 27 shares (grant or award)
  14. 4 Open-market sale President and CEO sold 9,922 shares at $10.01 ($99,319)
  15. 4 Planned sale Chief Scientific Officer sold 1,345 shares at $10.01 ($13,463)
  16. 4 Open-market sale Chief Legal Officer sold 3,480 shares at $9.67 ($33,652)
  17. 4 Open-market sale Chief Medical Officer sold 4,632 shares at $9.67 ($44,791)
  18. 4 Open-market sale Chief Scientific Officer sold 2,898 shares at $9.67 ($28,024)
  19. 4 Planned sale Chief Scientific Officer sold 3,143 shares at an average $12.23 ($38,433)
  20. 4 Planned sale Chief Scientific Officer sold 4,000 shares at $12.30 ($49,200)

Page 2 of 13 · 253 filings